185 related articles for article (PubMed ID: 29613980)
1. Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor.
Aydin R; Tezel TH
J Glaucoma; 2018 Jun; 27(6):e113-e116. PubMed ID: 29613980
[TBL] [Abstract][Full Text] [Related]
2. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS.
Seidman CJ; Finger PT; Silverman JS; Oratz R
Retin Cases Brief Rep; 2017 Winter; 11(1):47-50. PubMed ID: 26862924
[TBL] [Abstract][Full Text] [Related]
3. MANAGEMENT OF METASTATIC BREAST CARCINOMA OF IRIS WITH INTRAOCULAR BEVACIZUMAB INJECTIONS.
Akinci GE; Hondur AM; Tezel TH
Retin Cases Brief Rep; 2019 Summer; 13(3):220-223. PubMed ID: 28346258
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma.
Makri OE; Psachoulia C; Exarchou A; Georgakopoulos CD
J Glaucoma; 2016 Jan; 25(1):e53-5. PubMed ID: 25304284
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
Nakashima C; Keino H; Watanabe T; Taki W; Okada AA
Jpn J Ophthalmol; 2011 Jan; 55(1):80-1. PubMed ID: 21331703
[No Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.
Yokouchi H; Kitahashi M; Oshitari T; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2243-5. PubMed ID: 23250479
[No Abstract] [Full Text] [Related]
8. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report.
Jeong S; Sagong M; Chang W
BMC Ophthalmol; 2017 Mar; 17(1):25. PubMed ID: 28288603
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
10. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
[TBL] [Abstract][Full Text] [Related]
11. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
Nagendran ST; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
[TBL] [Abstract][Full Text] [Related]
12. [Use of bevacizumab as an additional strategy in angle closure glaucoma--case report].
Helemejko I; Jurowska-Liput J
Klin Oczna; 2010; 112(1-3):61-2. PubMed ID: 20572507
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab in treatment of iris metastasis from primary lung carcinoma.
Raval V; Saldanha M; Mittal R; Das T
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31501176
[TBL] [Abstract][Full Text] [Related]
14. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
[TBL] [Abstract][Full Text] [Related]
15. The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS Registry.
Atchison EA; Wood KM; Mattox CG; Barry CN; Lum F; MacCumber MW
Ophthalmology; 2018 May; 125(5):676-682. PubMed ID: 29336897
[TBL] [Abstract][Full Text] [Related]
16. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
17. Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.
Maudgil A; Sears KS; Rundle PA; Rennie IG; Salvi SM
Eye (Lond); 2015 May; 29(5):707-11. PubMed ID: 25771814
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
[No Abstract] [Full Text] [Related]
20. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
